Kopsavilkums
An ultra-high-performance liquid chromatography-mass spectrometry (UPLC/MS/MS) method was developed and validated for the quantification of trimethylamine-N-oxide (TMAO) simultaneously with TMAO-related molecules l-carnitine and γ-butyrobetaine (GBB) in human blood plasma. The separation of analytes was achieved using a Hydrophilic interaction liquid chromatography (HILIC)-type column with ammonium acetate-acetonitrile as the mobile phase. TMAO determination was validated according to valid US Food and Drug Administration guidelines. The developed method was successfully applied to plasma samples from healthy volunteers.
| Oriģinālvaloda | Angļu |
|---|---|
| Lapas (no-līdz) | 1670-1674 |
| Lapu skaits | 5 |
| Žurnāls | Biomedical Chromatography |
| Sējums | 29 |
| Izdevuma numurs | 11 |
| DOIs | |
| Publikācijas statuss | Publicēts - nov. 2015 |
Nospiedums
Uzziniet vairāk par pētniecības tēmām “Determination of trimethylamine-N-oxide in combination with l-carnitine and γ-butyrobetaine in human plasma by UPLC/MS/MS”. Kopā tie veido unikālu nospiedumu.Citēt šo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver